JP Morgan's Top 15 Stock Picks for 2023 and Now
In this piece, we will take a look at JP Morgan's top 15 stock picks for 2023 and most recent stock picks.
Regeneron Pharmaceuticals Inc. (REGN)
Market is closed
News
- First
- << Previous
- 31 - 40
- Next >>
Top 20 Drug Companies in the US by Revenue
Following the Covid-19 pandemic, which drastically altered the way of living, the top pharmaceutical or drug companies in the world became the center of attention for people everywhere due to the spike...
Regeneron Pharmaceuticals (REGN): Bronte Capital’s Biggest Winner of This Quarter
Bronte Capital, an investment management company, released its “Amalthea Fund” third-quarter 2023 investor letter. A copy of the same can be downloaded here.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q3 2023 Earnings Call Transcript
Operator: Welcome to the Regeneron Pharmaceuticals Third Quarter 2023 Earnings Conference Call. My name is Shannon, and I will be your operator for today's call.
5 Cheap Biotech Stocks Smart Investors Are Piling Into
In this piece, we will take a look at five cheap biotechnology stocks that smart investors are piling into.
Top 30 Oncology Companies in the World
In this article, we shall cover the top 30 oncology companies in the world.
14 Best Cancer Stocks To Buy Now
The global oncology landscape continues to evolve, with ongoing efforts to discover, develop, and provide innovative treatments aimed at improving outcomes for a growing number of patients.
5 Best 52-Week High Stocks To Buy Now
Lifestyle retailer Abercrombie & Fitch Co. (NYSE:ANF) is one of the best 52-week high stocks to buy now. Abercrombie & Fitch Co.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q2 2023 Earnings Call Transcript
Operator: Welcome to the Regeneron Pharmaceuticals Second Quarter 2023 Earnings Conference Call. My name is Shannon and I will be your operator for today's call.
Analysts Are Downgrading These 5 Stocks
On June 28, Morgan Stanley analyst Craig Hettenbach adopted a less optimistic perspective on Veeva Systems Inc. (NYSE:VEEV), attributing it to potential competition from Salesforce CRM.
- First
- << Previous
- 31 - 40
- Next >>
Billionaire Hedge Funds
